Celldex

$14.81
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$1.04 (-6.56%) As of 11:22 AM EDT today

Why Robinhood?

You can buy or sell Celldex and other stocks, options, and ETFs commission-free!

About CLDX

Celldex Therapeutics, Inc. engages in the business of development, manufacturing and commercialization of novel therapeutics for human health care. Its drug candidates have the ability to engage the human immune system and directly inhibit tumors to treat specific types of cancer and other diseases. Read More Its pipeline includes Varlilumab, CDX-1140, and CDX-301, and CDX-3379. The company was founded by Anthony S. Marucci and Tibor Keler in 1983 and is headquartered in Hampton, NJ. The listed name for CLDX is Celldex Therapeutics, Inc.

Employees
130
Headquarters
Hampton, New Jersey
Founded
1983
Market Cap
584.94M
Price-Earnings Ratio
Dividend Yield
Average Volume
458.03K
High Today
$15.47
Low Today
$14.74
Open Price
$15.40
Volume
125.47K
52 Week High
$19.32
52 Week Low
$1.50

Collections

CLDX Earnings

-$1.40
-$0.93
-$0.47
$0.00
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Q2 2020
Q3 2020
Estimated
per share
Actual
Expected Nov 10, After Hours

You May Also Like